What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis

BACKGROUND AND AIM: Trials of treatments for non-alcoholic steatohepatitis require endpoint assessment with liver biopsies. Previous large-scale trials have calculated their sample size expecting high retention but on average did not achieve this. We aimed to quantify the proportion of participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutoukidis, Dimitrios A., Morris, Elizabeth, Henry, John A., Shammoon, Yusra, Zimmerman, Matthew, Michalopoulou, Moscho, Jebb, Susan A., Aveyard, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059856/
https://www.ncbi.nlm.nih.gov/pubmed/33882107
http://dx.doi.org/10.1371/journal.pone.0250385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059856/
https://www.ncbi.nlm.nih.gov/pubmed/33882107
http://dx.doi.org/10.1371/journal.pone.0250385

Ejemplares similares